WELL Welltower | $147.17
+1.1% | 4/17/2025 | Reiterated by | Wedbush | Analyst R. Anderson | Underperform -> Underperform | | Low | View details for Wedbush rating of Welltower (NYSE:WELL) on 4/17/2025 |
IMAX IMAX | $22.47
+3.2% | 4/17/2025 | Reiterated by | Wedbush | - | Outperform | $32.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 4/17/2025 |
RKT Rocket Companies | $12.08
-1.4% | 4/16/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Hold -> Outperform | $13.00 | Low | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 4/16/2025 |
KNSA Kiniksa Pharmaceuticals | $20.21
-1.6% | 4/16/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $34.00 -> $34.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 4/16/2025 |
NVCR NovoCure | $15.58
-1.6% | 4/16/2025 | Target Lowered by | Wedbush | Analyst David Nierengarten | Neutral -> Neutral | $29.00 -> $27.00 | Medium | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 4/16/2025 |
NVDA NVIDIA | $101.33
-3.0% | 4/16/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $175.00 -> $175.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 4/16/2025 |
BPMC Blueprint Medicines | $84.62
+3.1% | 4/16/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $128.00 -> $128.00 | Medium | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 4/16/2025 |
UMC United Microelectronics | $6.81
-0.7% | 4/16/2025 | Downgraded by | Wedbush | Analyst M. Bryson | Outperform -> Neutral | | Low | View details for Wedbush rating of United Microelectronics (NYSE:UMC) on 4/16/2025 |
META Meta Platforms | $501.48
-0.2% | 4/15/2025 | Target Lowered by | Wedbush | Analyst Meta Marshall | Outperform -> Outperform | $770.00 -> $680.00 | Low | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 4/15/2025 |
WDC Western Digital | $36.51
+2.5% | 4/11/2025 | Reiterated by | Wedbush | - | Underperform -> Underperform | | Low | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 4/11/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
SHOP Shopify | $83.65
-0.4% | 4/15/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $110.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 4/15/2025 |
SE SEA | $120.97
+1.9% | 4/15/2025 | Reiterated by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $135.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 4/15/2025 |
EXPE Expedia Group | $151.15
-0.9% | 4/15/2025 | Reiterated by | Wedbush | - | Neutral -> Neutral | | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 4/15/2025 |
PINS Pinterest | $25.17
-1.1% | 4/15/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | | Low | View details for Wedbush rating of Pinterest (NYSE:PINS) on 4/15/2025 |
GOOGL Alphabet | $151.08
-1.5% | 4/15/2025 | Target Set by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $190.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 4/15/2025 |
RUM Rumble | $7.16
+1.1% | 4/15/2025 | Target Set by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $8.00 | Medium | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 4/15/2025 |
DOC Healthpeak Properties | $18.75
+0.9% | 4/11/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $24.00 -> $24.00 | High | View details for Wedbush rating of Healthpeak Properties (NYSE:DOC) on 4/11/2025 |
ARGX argenx | $596.20
+1.5% | 4/11/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $715.00 -> $715.00 | Low | View details for Wedbush rating of argenx (NASDAQ:ARGX) on 4/11/2025 |
KMX CarMax | $64.50
+0.6% | 4/11/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $100.00 -> $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/11/2025 |
NFLX Netflix | $973.03
+1.2% | 4/11/2025 | Reiterated by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $1,150.00 -> $1,150.00 | Medium | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 4/11/2025 |
MSFT Microsoft | $367.78
-1.0% | 4/10/2025 | Target Lowered by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $550.00 -> $475.00 | High | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 4/10/2025 |
HR Healthcare Realty Trust | $15.98
+1.8% | 4/7/2025 | Upgraded by | Wedbush | Analyst R. Anderson | Strong Sell -> Hold | | High | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 4/7/2025 |
KURA Kura Oncology | $5.90
+2.6% | 4/8/2025 | Reiterated by | Wedbush | - | Outperform | $36.00 | Medium | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 4/8/2025 |
WVE Wave Life Sciences | $5.92
+1.4% | 4/8/2025 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $18.00 | High | View details for Wedbush rating of Wave Life Sciences (NASDAQ:WVE) on 4/8/2025 |
AAPL Apple | $196.79
+1.3% | 4/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $325.00 -> $250.00 | Medium | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 4/7/2025 |
TSLA Tesla | $241.17
-0.2% | 4/7/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $315.00 | High | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 4/7/2025 |
GME GameStop | $26.81
+2.1% | 3/26/2025 | Target Set by | Wedbush | - | | $11.50 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/26/2025 |
CMPX Compass Therapeutics | $1.75
+2.9% | 4/1/2025 | Reiterated by | Wedbush | - | Outperform | $8.00 | High | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 4/1/2025 |
KROS Keros Therapeutics | $14.07
+4.0% | 4/1/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Neutral -> Neutral | $15.00 -> $15.00 | High | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 4/1/2025 |
KMX CarMax | $64.50
+0.6% | 4/1/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $100.00 -> $100.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 4/1/2025 |
PRGS Progress Software | $56.00
-0.1% | 4/1/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $75.00 -> $75.00 | High | View details for Wedbush rating of Progress Software (NASDAQ:PRGS) on 4/1/2025 |
MNRO Monro | $13.96
+1.6% | 4/1/2025 | Target Lowered by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $27.00 -> $19.00 | Medium | View details for Wedbush rating of Monro (NASDAQ:MNRO) on 4/1/2025 |
SAFE Safehold | $15.28
+0.7% | 3/31/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Neutral -> Neutral | $20.00 -> $20.00 | High | View details for Wedbush rating of Safehold (NYSE:SAFE) on 3/31/2025 |
BROS Dutch Bros | $58.26
+0.9% | 3/31/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $90.00 -> $90.00 | Medium | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 3/31/2025 |
TYRA Tyra Biosciences | $8.92
+3.6% | 3/28/2025 | Reiterated by | Wedbush | - | Outperform | $30.00 | Medium | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 3/28/2025 |
VRNT Verint Systems | $15.99
+0.2% | 3/28/2025 | Target Lowered by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $38.00 -> $30.00 | Medium | View details for Wedbush rating of Verint Systems (NASDAQ:VRNT) on 3/28/2025 |
TMC TMC the metals | $2.96
+6.1% | 3/28/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Wedbush rating of TMC the metals (NASDAQ:TMC) on 3/28/2025 |
RITM Rithm Capital | $10.13
+1.1% | 3/28/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $14.00 -> $14.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 3/28/2025 |
PTGX Protagonist Therapeutics | $46.28
+1.0% | 3/28/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $70.00 -> $70.00 | Medium | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/28/2025 |
ZNTL Zentalis Pharmaceuticals | $1.29
+2.4% | 3/28/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 3/28/2025 |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
TXRH Texas Roadhouse | $161.89
+0.9% | 3/28/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $200.00 -> $210.00 | High | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 3/28/2025 |
NUVB Nuvation Bio | $1.97
+4.5% | 3/27/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | Medium | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 3/27/2025 |
BCAX Bicara Therapeutics | $12.16
+3.4% | 3/27/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $31.00 | Low | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 3/27/2025 |
CHWY Chewy | $35.18
+1.2% | 3/27/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $39.00 -> $39.00 | Medium | View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/27/2025 |
WOOF Petco Health and Wellness | $3.09
-0.3% | 3/27/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $6.00 -> $4.00 | High | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 3/27/2025 |
TSLA Tesla | $241.17
-0.2% | 3/27/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $550.00 | Medium | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/27/2025 |
CATX Perspective Therapeutics | $1.94
+4.9% | 3/26/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $11.00 -> $11.00 | Medium | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 3/26/2025 |
RH RH | $160.42
+4.3% | 3/26/2025 | Target Lowered by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $500.00 -> $350.00 | Low | View details for Wedbush rating of RH (NYSE:RH) on 3/26/2025 |
PRPL Purple Innovation | $0.56
-1.6% | 3/26/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $1.00 -> $1.00 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/26/2025 |
RUM Rumble | $7.16
+1.1% | 3/26/2025 | Target Lowered by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $13.00 -> $10.00 | Low | View details for Wedbush rating of Rumble (NASDAQ:RUM) on 3/26/2025 |
HURN Huron Consulting Group | $141.50
+0.0% | 3/26/2025 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $150.00 -> $165.00 | Medium | View details for Wedbush rating of Huron Consulting Group (NASDAQ:HURN) on 3/26/2025 |
SRRK Scholar Rock | $30.71
+3.2% | 3/25/2025 | Reiterated by | Wedbush | - | Outperform | $50.00 | High | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 3/25/2025 |
KBH KB Home | $51.59
+2.9% | 3/25/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $75.00 -> $75.00 | High | View details for Wedbush rating of KB Home (NYSE:KBH) on 3/25/2025 |
ALIT Alight | $5.00
-0.7% | 3/25/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $11.00 -> $11.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 3/25/2025 |
OKLO Oklo | $21.99
+2.0% | 3/25/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $45.00 -> $45.00 | Medium | View details for Wedbush rating of Oklo (NYSE:OKLO) on 3/25/2025 |
ARTV Artiva Biotherapeutics | $2.24
-2.6% | 3/25/2025 | Reiterated by | Wedbush | Analyst Martin Fan | Outperform -> Outperform | $18.00 -> $18.00 | Medium | View details for Wedbush rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/25/2025 |
GME GameStop | $26.81
+2.1% | 3/24/2025 | Reiterated by | Wedbush | - | Underperform -> Underperform | $10.00 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/24/2025 |
ELEV Elevation Oncology | $0.39
+16.7% | 3/20/2025 | Downgraded by | Wedbush | Analyst R. Driscoll | Strong-Buy -> Hold | | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/20/2025 |
ASO Academy Sports and Outdoors | $37.85
+3.3% | 3/21/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $65.00 -> $60.00 | Medium | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/21/2025 |
DRI Darden Restaurants | $200.03
+1.1% | 3/21/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $220.00 -> $235.00 | Medium | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/21/2025 |
VOR Vor Biopharma | $0.65
| 3/20/2025 | Reiterated by | Wedbush | - | Outperform | $7.00 | High | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 3/20/2025 |
GLUE Monte Rosa Therapeutics | $4.55
+3.2% | 3/20/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $15.00 -> $17.00 | High | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 3/20/2025 |
ORIC ORIC Pharmaceuticals | $4.77
+1.7% | 3/20/2025 | Reiterated by | Wedbush | - | Outperform | $20.00 | High | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/20/2025 |
AVTX Avalo Therapeutics | $4.41
-4.8% | 3/20/2025 | Reiterated by | Wedbush | Analyst R. Driscoll | Outperform | $18.00 | Low | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 3/20/2025 |
IMNM Immunome | $7.91
+10.3% | 3/20/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $33.00 -> $33.00 | Medium | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 3/20/2025 |
WSM Williams-Sonoma | $139.04
+1.0% | 3/20/2025 | Target Lowered by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $190.00 -> $170.00 | Medium | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/20/2025 |
MSFT Microsoft | $367.78
-1.0% | 3/20/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $550.00 -> $550.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 3/20/2025 |
TSLA Tesla | $241.17
-0.2% | 3/20/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $550.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/20/2025 |
ZBIO Zenas Biopharma | $8.92
+7.1% | 3/20/2025 | Initiated by | Wedbush | Analyst Martin Fan | Outperform | $35.00 | Medium | View details for Wedbush rating of Zenas Biopharma (NASDAQ:ZBIO) on 3/20/2025 |
BYON Beyond | $4.11
+11.4% | 3/19/2025 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 3/19/2025 |
BDTX Black Diamond Therapeutics | $1.44
+5.9% | 3/19/2025 | Reiterated by | Wedbush | - | Outperform | $11.00 | High | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/19/2025 |
PRME Prime Medicine | $1.24
| 3/18/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 -> $13.00 | High | View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 3/18/2025 |
GEO The GEO Group | $29.60
+1.8% | 3/18/2025 | Reiterated by | Wedbush | - | Outperform | $46.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/18/2025 |
CATX Perspective Therapeutics | $1.94
+4.9% | 3/17/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $11.00 | High | View details for Wedbush rating of Perspective Therapeutics (NYSE:CATX) on 3/17/2025 |
SRRK Scholar Rock | $30.71
+3.2% | 3/17/2025 | Reiterated by | Wedbush | - | Outperform | $50.00 | Medium | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 3/17/2025 |
NHI National Health Investors | $75.44
+0.2% | 3/17/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $88.00 -> $88.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/17/2025 |
LEN Lennar | $104.57
+1.8% | 3/17/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $158.00 -> $158.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/17/2025 |
CHWY Chewy | $35.18
+1.2% | 3/17/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $39.00 -> $39.00 | Low | View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/17/2025 |
MU Micron Technology | $68.80
-0.8% | 3/17/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $125.00 -> $125.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/17/2025 |
GBIO Generation Bio | $0.39
+12.4% | 3/14/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | High | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 3/14/2025 |
SKLZ Skillz | $4.45
+3.7% | 3/14/2025 | Reiterated by | Wedbush | - | Outperform | $15.00 | High | View details for Wedbush rating of Skillz (NYSE:SKLZ) on 3/14/2025 |
GOSS Gossamer Bio | $0.84
+1.2% | 3/14/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $4.00 -> $4.00 | High | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 3/14/2025 |
VIGL Vigil Neuroscience | $1.71
+13.2% | 3/14/2025 | Target Lowered by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $24.00 -> $13.00 | Medium | View details for Wedbush rating of Vigil Neuroscience (NASDAQ:VIGL) on 3/14/2025 |
TRML Tourmaline Bio | $16.01
+10.3% | 3/14/2025 | Target Raised by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $42.00 -> $43.00 | High | View details for Wedbush rating of Tourmaline Bio (NASDAQ:TRML) on 3/14/2025 |
AAPL Apple | $196.79
+1.3% | 3/14/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $325.00 -> $325.00 | Medium | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 3/14/2025 |
DOCU DocuSign | $75.42
-1.3% | 3/14/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Neutral -> Neutral | $100.00 -> $100.00 | High | View details for Wedbush rating of DocuSign (NASDAQ:DOCU) on 3/14/2025 |
RBRK Rubrik | $61.48
-1.3% | 3/14/2025 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $75.00 -> $80.00 | High | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 3/14/2025 |
TBCH Turtle Beach | $10.91
-0.5% | 3/14/2025 | Target Raised by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $20.00 -> $21.00 | High | View details for Wedbush rating of Turtle Beach (NASDAQ:TBCH) on 3/14/2025 |
CTRE CareTrust REIT | $28.76
+0.5% | 3/14/2025 | Reiterated by | Wedbush | Analyst R. Anderson | Underperform -> Underperform | $26.00 -> $26.00 | Medium | View details for Wedbush rating of CareTrust REIT (NASDAQ:CTRE) on 3/14/2025 |
STRO Sutro Biopharma | $0.53
-2.2% | 3/14/2025 | Downgraded by | Wedbush | Analyst David Nierengarten | Outperform -> Neutral | $8.00 -> $2.00 | High | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 3/14/2025 |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
NCMI National CineMedia | $5.92
+1.9% | 3/14/2025 | Upgraded by | Wedbush | Analyst Alicia Reese | Neutral -> Outperform | $7.50 -> $7.50 | Medium | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/14/2025 |
GETY Getty Images | $1.74
+4.5% | 3/13/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $7.70 -> $7.70 | Low | View details for Wedbush rating of Getty Images (NYSE:GETY) on 3/13/2025 |
CRBP Corbus Pharmaceuticals | $6.03
+1.9% | 3/12/2025 | Reiterated by | Wedbush | - | Outperform | $51.00 | Medium | View details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 3/12/2025 |
DKS DICK'S Sporting Goods | $185.33
+2.6% | 3/12/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $215.00 -> $215.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/12/2025 |
RMBL RumbleOn | $2.37
-2.1% | 3/12/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $5.50 -> $5.00 | High | View details for Wedbush rating of RumbleOn (NASDAQ:RMBL) on 3/12/2025 |
PAY Paymentus | $29.02
-0.3% | 3/12/2025 | Reiterated by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $38.00 -> $38.00 | Medium | View details for Wedbush rating of Paymentus (NYSE:PAY) on 3/12/2025 |
DNTH Dianthus Therapeutics | $19.50
+2.7% | 3/12/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $36.00 -> $36.00 | High | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
VYGR Voyager Therapeutics | $3.16
+1.0% | 3/12/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | | High | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/12/2025 |
HOWL Werewolf Therapeutics | $0.92
+8.4% | 3/12/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $8.00 -> $8.00 | High | View details for Wedbush rating of Werewolf Therapeutics (NASDAQ:HOWL) on 3/12/2025 |
PTGX Protagonist Therapeutics | $46.28
+1.0% | 3/11/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform -> Outperform | $70.00 | High | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/11/2025 |
ATXS Astria Therapeutics | $4.04
+1.5% | 3/12/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $27.00 -> $28.00 | High | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/12/2025 |
OVID Ovid Therapeutics | $0.29
+6.5% | 3/12/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $4.00 -> $3.00 | High | View details for Wedbush rating of Ovid Therapeutics (NASDAQ:OVID) on 3/12/2025 |
ARVN Arvinas | $8.60
+12.4% | 3/12/2025 | Downgraded by | Wedbush | Analyst Robert Driscoll | Outperform -> Neutral | $57.00 -> $12.00 | High | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 3/12/2025 |
APGE Apogee Therapeutics | $33.11
+3.3% | 3/11/2025 | Reiterated by | Wedbush | - | Outperform | $90.00 | High | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 3/11/2025 |
TLS Telos | $2.50
-0.8% | 3/11/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $6.00 -> $6.00 | High | View details for Wedbush rating of Telos (NASDAQ:TLS) on 3/11/2025 |
STKS ONE Group Hospitality | $2.78
+3.0% | 3/11/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $3.50 -> $3.50 | High | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/11/2025 |
WLDN Willdan Group | $38.48
-0.3% | 3/10/2025 | Upgraded by | Wedbush | Analyst D. Ives | Strong-Buy | | Low | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 3/10/2025 |
FENC Fennec Pharmaceuticals | $5.08
-0.4% | 3/10/2025 | Reiterated by | Wedbush | - | Outperform | $13.00 | High | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/10/2025 |
INZY Inozyme Pharma | $0.92
-4.4% | 3/10/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 -> $7.00 | High | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 3/10/2025 |
BEAM Beam Therapeutics | $17.00
+2.3% | 3/10/2025 | Reiterated by | Wedbush | - | Outperform | $57.00 | High | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 3/10/2025 |
IMNM Immunome | $7.91
+10.3% | 3/10/2025 | Reiterated by | Wedbush | - | Outperform | $33.00 | Low | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 3/10/2025 |
PLYM Plymouth Industrial REIT | $14.54
+1.6% | 2/28/2025 | Target Set by | Wedbush | - | | $17.00 | Medium | View details for Wedbush rating of Plymouth Industrial REIT (NYSE:PLYM) on 2/28/2025 |
WLDN Willdan Group | $38.48
-0.3% | 3/7/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $51.00 -> $56.00 | Low | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 3/7/2025 |
BDTX Black Diamond Therapeutics | $1.44
+5.9% | 3/7/2025 | Reiterated by | Wedbush | - | Outperform | $16.00 -> $11.00 | Medium | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/7/2025 |
CTMX CytomX Therapeutics | $0.66
+4.2% | 3/7/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | High | View details for Wedbush rating of CytomX Therapeutics (NASDAQ:CTMX) on 3/7/2025 |
ORKA Oruka Therapeutics | $9.22
+7.0% | 3/7/2025 | Reiterated by | Wedbush | - | Outperform | $40.00 | Medium | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 3/7/2025 |
LOGI Logitech International | $71.63
+2.1% | 3/7/2025 | Upgraded by | Wedbush | Analyst Alicia Reese | Neutral -> Outperform | $100.00 -> $125.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 3/7/2025 |
WEN Wendy's | $12.68
+1.1% | 3/7/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $16.00 -> $16.00 | Medium | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 3/7/2025 |
TSLA Tesla | $241.17
-0.2% | 3/7/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $550.00 -> $550.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/7/2025 |
FATE Fate Therapeutics | $1.11
+5.7% | 3/6/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Neutral -> Neutral | $5.00 -> $5.00 | High | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 3/6/2025 |
DKS DICK'S Sporting Goods | $185.33
+2.6% | 3/6/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $215.00 -> $215.00 | Medium | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/6/2025 |
SNBR Sleep Number | $5.28
+8.6% | 3/6/2025 | Target Lowered by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $18.00 -> $12.00 | High | View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 3/6/2025 |
ZS Zscaler | $201.09
-0.9% | 3/6/2025 | Target Raised by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $230.00 -> $240.00 | Low | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 3/6/2025 |
MDB MongoDB | $159.26
-0.5% | 3/6/2025 | Target Lowered by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $360.00 -> $300.00 | High | View details for Wedbush rating of MongoDB (NASDAQ:MDB) on 3/6/2025 |
DIN Dine Brands Global | $20.21
+3.9% | 3/6/2025 | Target Lowered by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $28.00 -> $26.00 | High | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 3/6/2025 |
TRML Tourmaline Bio | $16.01
+10.3% | 3/6/2025 | Initiated by | Wedbush | Analyst Laura Chico | Outperform | $42.00 | High | View details for Wedbush rating of Tourmaline Bio (NASDAQ:TRML) on 3/6/2025 |
TCRX TScan Therapeutics | $1.44
+10.8% | 3/5/2025 | Reiterated by | Wedbush | - | Outperform | $7.00 | High | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 3/5/2025 |
ITOS iTeos Therapeutics | $6.51
+4.7% | 3/5/2025 | Reiterated by | Wedbush | - | Outperform | $25.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/5/2025 |
NCMI National CineMedia | $5.92
+1.9% | 3/5/2025 | Reiterated by | Wedbush | - | Neutral | $7.50 | Medium | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/5/2025 |
CMRX Chimerix | $8.54
-0.1% | 3/5/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $7.00 -> $8.55 | High | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 3/5/2025 |
RKT Rocket Companies | $12.08
-1.4% | 3/5/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $13.00 -> $13.00 | High | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 3/5/2025 |
STRW Strawberry Fields REIT | $10.97
+4.6% | 3/5/2025 | Target Raised by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $12.00 -> $14.00 | Medium | View details for Wedbush rating of Strawberry Fields REIT (NASDAQ:STRW) on 3/5/2025 |
LSEA Landsea Homes | $5.93
+2.8% | 3/5/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Outperform -> Outperform | $15.00 -> $15.00 | Low | View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 3/5/2025 |
AZO AutoZone | $3,601.29
+1.0% | 3/5/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $3,700.00 -> $3,700.00 | Medium | View details for Wedbush rating of AutoZone (NYSE:AZO) on 3/5/2025 |
CRWD CrowdStrike | $375.62
-1.1% | 3/5/2025 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $390.00 -> $395.00 | High | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2025 |
RC Ready Capital | $4.40
+4.6% | 3/4/2025 | Reiterated by | Wedbush | - | Neutral | $8.00 -> $6.00 | High | View details for Wedbush rating of Ready Capital (NYSE:RC) on 3/4/2025 |
PRAX Praxis Precision Medicines | $33.79
+13.3% | 2/28/2025 | Downgraded by | Wedbush | Analyst L. Chico | Hold -> Strong Sell | | High | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 2/28/2025 |
NUVB Nuvation Bio | $1.97
+4.5% | 3/3/2025 | Reiterated by | Wedbush | - | Outperform | $5.00 | Low | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 3/3/2025 |
YMAB Y-mAbs Therapeutics | $4.69
+3.3% | 3/3/2025 | Reiterated by | Wedbush | - | Outperform | $23.00 | High | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 3/3/2025 |
MRSN Mersana Therapeutics | $0.35
+5.6% | 3/3/2025 | Reiterated by | Wedbush | - | Outperform | $4.00 | Medium | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 3/3/2025 |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
APGE Apogee Therapeutics | $33.11
+3.3% | 3/3/2025 | Reiterated by | Wedbush | - | Outperform | $90.00 | High | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 3/3/2025 |
UWMC UWM | $4.53
-0.5% | 3/3/2025 | Reiterated by | Wedbush | Analyst Jay McCanless | Neutral -> Neutral | $6.50 -> $6.50 | Medium | View details for Wedbush rating of UWM (NYSE:UWMC) on 3/3/2025 |
APLS Apellis Pharmaceuticals | $18.20
+0.2% | 3/3/2025 | Target Lowered by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $30.00 -> $29.00 | High | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 3/3/2025 |
BBY Best Buy | $61.97
+3.9% | 3/3/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $90.00 -> $90.00 | High | View details for Wedbush rating of Best Buy (NYSE:BBY) on 3/3/2025 |
AAP Advance Auto Parts | $31.79
+3.0% | 3/3/2025 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $55.00 -> $55.00 | High | View details for Wedbush rating of Advance Auto Parts (NYSE:AAP) on 3/3/2025 |
PLTR Palantir Technologies | $93.78
+1.2% | 3/3/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $120.00 -> $120.00 | N/A | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 3/3/2025 |
AAPL Apple | $196.79
+1.3% | 3/3/2025 | Reiterated by | Wedbush | Analyst Daniel Ives | Outperform -> Outperform | $325.00 -> $325.00 | Medium | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 3/3/2025 |
FUBO FuboTV | $2.97
+3.3% | 2/28/2025 | Reiterated by | Wedbush | - | Outperform | $6.40 | Low | View details for Wedbush rating of FuboTV (NYSE:FUBO) on 2/28/2025 |
GRBK Green Brick Partners | $55.75
+1.5% | 2/28/2025 | Reiterated by | Wedbush | - | Neutral | $70.00 | Low | View details for Wedbush rating of Green Brick Partners (NASDAQ:GRBK) on 2/28/2025 |
BPMC Blueprint Medicines | $84.62
+3.1% | 2/28/2025 | Reiterated by | Wedbush | - | Outperform | $128.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 2/28/2025 |
TSLA Tesla | $241.17
-0.2% | 2/26/2025 | Target Set by | Wedbush | - | | $302.80 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 2/26/2025 |
JANX Janux Therapeutics | $29.69
+3.5% | 2/28/2025 | Reiterated by | Wedbush | - | Outperform | $75.00 -> $76.00 | Medium | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 2/28/2025 |
WSM Williams-Sonoma | $139.04
+1.0% | 2/28/2025 | Reiterated by | Wedbush | Analyst S. Basham | Neutral | $175.00 -> $190.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 2/28/2025 |
NTAP NetApp | $82.61
+1.5% | 2/28/2025 | Reiterated by | Wedbush | - | Neutral | $120.00 -> $110.00 | High | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 2/28/2025 |
PRME Prime Medicine | $1.24
| 2/28/2025 | Reiterated by | Wedbush | - | Outperform | $12.00 | Medium | View details for Wedbush rating of Prime Medicine (NYSE:PRME) on 2/28/2025 |
PZZA Papa Johns International | $31.16
+0.4% | 2/28/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $60.00 -> $60.00 | High | View details for Wedbush rating of Papa Johns International (NASDAQ:PZZA) on 2/28/2025 |
DIN Dine Brands Global | $20.21
+3.9% | 2/28/2025 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Neutral | $47.00 -> $28.00 | High | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 2/28/2025 |
KURA Kura Oncology | $5.90
+2.6% | 2/27/2025 | Reiterated by | Wedbush | - | Outperform | $36.00 | Medium | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 2/27/2025 |
RVMD Revolution Medicines | $36.76
+1.5% | 2/27/2025 | Reiterated by | Wedbush | - | Outperform | $67.00 | Medium | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 2/27/2025 |
MNKD MannKind | $4.54
+0.2% | 2/27/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $11.00 | Low | View details for Wedbush rating of MannKind (NASDAQ:MNKD) on 2/27/2025 |
PLTK Playtika | $4.93
-1.2% | 2/26/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $11.50 -> $11.50 | High | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/26/2025 |
DAWN Day One Biopharmaceuticals | $6.84
+1.2% | 2/26/2025 | Reiterated by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $32.00 -> $32.00 | High | View details for Wedbush rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 2/26/2025 |
HD Home Depot | $354.85
+2.6% | 2/26/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Outperform -> Outperform | $440.00 -> $440.00 | Medium | View details for Wedbush rating of Home Depot (NYSE:HD) on 2/26/2025 |
CART Maplebear | $42.99
+2.2% | 2/26/2025 | Target Lowered by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $48.00 -> $46.00 | High | View details for Wedbush rating of Maplebear (NASDAQ:CART) on 2/26/2025 |
CAVA CAVA Group | $86.03
+0.6% | 2/26/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $150.00 -> $150.00 | High | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 2/26/2025 |
COGT Cogent Biosciences | $4.37
+2.3% | 2/25/2025 | Reiterated by | Wedbush | - | Neutral | $11.00 | Medium | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 2/25/2025 |
KNSA Kiniksa Pharmaceuticals | $20.21
-1.6% | 2/25/2025 | Reiterated by | Wedbush | - | Outperform | $34.00 | Medium | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 2/25/2025 |
BCRX BioCryst Pharmaceuticals | $7.40
+2.5% | 2/25/2025 | Initiated by | Wedbush | Analyst L. Chico | Outperform | $15.00 | Low | View details for Wedbush rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 2/25/2025 |
DPZ Domino's Pizza | $466.74
+1.0% | 2/25/2025 | Reiterated by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $500.00 -> $500.00 | High | View details for Wedbush rating of Domino’s Pizza (NASDAQ:DPZ) on 2/25/2025 |
CAT Caterpillar | $293.82
+1.3% | 2/3/2025 | Upgraded by | Wedbush | - | Outperform | | Low | View details for Wedbush rating of Caterpillar (NYSE:CAT) on 2/3/2025 |
MGM MGM Resorts International | $28.89
+1.5% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform -> Outperform | | N/A | View details for Wedbush rating of MGM Resorts International (NYSE:MGM) on 2/13/2025 |
INFA Informatica | $17.53
+0.8% | 2/14/2025 | Downgraded by | Wedbush | - | Neutral | | N/A | View details for Wedbush rating of Informatica (NYSE:INFA) on 2/14/2025 |
SMCI Super Micro Computer | $31.50
-1.2% | 2/18/2025 | Reiterated by | Wedbush | - | Hold -> Hold | | N/A | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 2/18/2025 |
SNOW Snowflake | $143.34
-1.9% | 1/22/2025 | Target Set by | Wedbush | Analyst D. Ives | | $210.00 | High | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 1/22/2025 |
CINT CI&T | $4.98
+1.1% | 2/3/2025 | Target Set by | Wedbush | Analyst D. Ives | | $9.00 | High | View details for Wedbush rating of CI&T (NYSE:CINT) on 2/3/2025 |
TSLA Tesla | $241.17
-0.2% | 2/12/2025 | Target Set by | Wedbush | Analyst Dan Ives | | $328.50 | Medium | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 2/12/2025 |
CVNA Carvana | $211.03
+0.8% | 2/19/2025 | Target Set by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $250.00 | Medium | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/19/2025 |
AVTX Avalo Therapeutics | $4.41
-4.8% | 2/20/2025 | Upgraded by | Wedbush | Analyst R. Driscoll | Strong-Buy | | High | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 2/20/2025 |
PTGX Protagonist Therapeutics | $46.28
+1.0% | 2/21/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $58.00 | Low | View details for Wedbush rating of Protagonist Therapeutics (NASDAQ:PTGX) on 2/21/2025 |
W Wayfair | $26.58
+5.7% | 2/21/2025 | Reiterated by | Wedbush | Analyst S. Basham | Neutral | $44.00 -> $46.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/21/2025 |
AXTI AXT | $1.19
+1.7% | 2/21/2025 | Reiterated by | Wedbush | - | Outperform | $5.50 -> $4.50 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/21/2025 |
BJRI BJ's Restaurants | $32.40
+3.1% | 2/21/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $43.00 -> $48.00 | High | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 2/21/2025 |
AVTX Avalo Therapeutics | $4.41
-4.8% | 2/21/2025 | Initiated by | Wedbush | - | Outperform | $18.00 | High | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 2/21/2025 |
TXRH Texas Roadhouse | $161.89
+0.9% | 2/21/2025 | Target Lowered by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $220.00 -> $200.00 | High | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/21/2025 |
SHAK Shake Shack | $83.57
+3.9% | 2/21/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $115.00 -> $125.00 | High | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 2/21/2025 |
JACK Jack in the Box | $23.22
+1.6% | 2/21/2025 | Downgraded by | Wedbush | Analyst N. Setyan | Outperform -> Neutral | $50.00 -> $40.00 | Medium | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 2/21/2025 |
BMRN BioMarin Pharmaceutical | $59.17
+0.6% | 2/20/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $94.00 | Low | View details for Wedbush rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/20/2025 |
HR Healthcare Realty Trust | $15.98
+1.8% | 2/20/2025 | Reiterated by | Wedbush | Analyst R. Anderson | Outperform | $16.00 | Low | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 2/20/2025 |
SWTX SpringWorks Therapeutics | $37.89
+0.4% | 2/20/2025 | Reiterated by | Wedbush | - | Outperform | $81.00 | High | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/20/2025 |
IMAX IMAX | $22.47
+3.2% | 2/20/2025 | Reiterated by | Wedbush | - | Outperform | $32.00 | High | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/20/2025 |
Trump Treasure April 19 (Ad) Thanks to President Trump…
A $900 investment across5 specific cryptos…
Could gain 12,000% so quickly that, just 12 months later… If I’m right about this (like I was before) a modest $900 investment… |
NVDA NVIDIA | $101.33
-3.0% | 2/20/2025 | Reiterated by | Wedbush | - | Outperform | $175.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/20/2025 |
WING Wingstop | $218.84
+0.5% | 2/20/2025 | Target Lowered by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $390.00 -> $355.00 | High | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/20/2025 |
CAKE Cheesecake Factory | $47.87
+2.3% | 2/20/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $59.00 -> $61.00 | High | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 2/20/2025 |
WOOF Petco Health and Wellness | $3.09
-0.3% | 2/19/2025 | Reiterated by | Wedbush | - | Outperform | $6.00 | Medium | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 2/19/2025 |
TPH Tri Pointe Homes | $29.50
+1.5% | 2/18/2025 | Reiterated by | Wedbush | - | Neutral | $44.00 -> $38.00 | High | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 2/18/2025 |
CMRX Chimerix | $8.54
-0.1% | 2/18/2025 | Reiterated by | Wedbush | - | Outperform | $6.00 -> $7.00 | High | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 2/18/2025 |
RH RH | $160.42
+4.3% | 2/18/2025 | Reiterated by | Wedbush | Analyst S. Basham | Outperform | $500.00 | High | View details for Wedbush rating of RH (NYSE:RH) on 2/18/2025 |
CNK Cinemark | $28.47
+1.6% | 2/18/2025 | Reiterated by | Wedbush | Analyst A. Reese | Neutral | $32.00 | Medium | View details for Wedbush rating of Cinemark (NYSE:CNK) on 2/18/2025 |
TOL Toll Brothers | $93.87
+2.2% | 2/14/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $175.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 2/14/2025 |
DOC Healthpeak Properties | $18.75
+0.9% | 2/14/2025 | Target Lowered by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $27.00 -> $24.00 | Low | View details for Wedbush rating of Healthpeak Properties (NYSE:DOC) on 2/14/2025 |
VTR Ventas | $67.79
+0.2% | 2/14/2025 | Target Raised by | Wedbush | Analyst Richard Anderson | Outperform -> Outperform | $69.00 -> $78.00 | Medium | View details for Wedbush rating of Ventas (NYSE:VTR) on 2/14/2025 |
WEN Wendy's | $12.68
+1.1% | 2/14/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Neutral -> Neutral | $15.50 -> $16.00 | High | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/14/2025 |
WELL Welltower | $147.17
+1.1% | 2/14/2025 | Upgraded by | Wedbush | Analyst Richard Anderson | Neutral -> Outperform | $145.00 -> $167.00 | Low | View details for Wedbush rating of Welltower (NYSE:WELL) on 2/14/2025 |
FND Floor & Decor | $70.12
+1.6% | 2/14/2025 | Downgraded by | Wedbush | Analyst Seth Basham | Outperform -> Neutral | $110.00 -> $100.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/14/2025 |
BPMC Blueprint Medicines | $84.62
+3.1% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform | $124.00 -> $128.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 2/13/2025 |
U Unity Software | $19.20
+1.6% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform | $27.00 | High | View details for Wedbush rating of Unity Software (NYSE:U) on 2/13/2025 |
DBD Diebold Nixdorf | $41.95
-0.2% | 2/13/2025 | Reiterated by | Wedbush | - | Outperform | $60.00 | Medium | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 2/13/2025 |
BROS Dutch Bros | $58.26
+0.9% | 2/13/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $65.00 -> $100.00 | High | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 2/13/2025 |
DENN Denny's | $3.11
+5.1% | 2/13/2025 | Target Lowered by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $10.00 -> $8.50 | High | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/13/2025 |
ANAB AnaptysBio | $20.55
+7.8% | 2/12/2025 | Reiterated by | Wedbush | - | Outperform | $40.00 | High | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 2/12/2025 |
LYFT Lyft | $11.16
+3.0% | 2/12/2025 | Target Lowered by | Wedbush | Analyst S. Devitt | Neutral -> Neutral | $18.00 -> $16.00 | High | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 2/12/2025 |
DASH DoorDash | $181.24
+1.0% | 2/12/2025 | Target Raised by | Wedbush | Analyst Scott Devitt | Neutral -> Neutral | $160.00 -> $210.00 | Medium | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 2/12/2025 |
GFS GlobalFoundries | $31.70
+0.3% | 2/12/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $60.00 -> $60.00 | Medium | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 2/12/2025 |
SMCI Super Micro Computer | $31.50
-1.2% | 2/12/2025 | Target Raised by | Wedbush | Analyst Matt Bryson | Neutral -> Neutral | $24.00 -> $40.00 | Low | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 2/12/2025 |
DDI DoubleDown Interactive | $9.85
-3.1% | 2/12/2025 | Reiterated by | Wedbush | Analyst Michael Pachter | Outperform -> Outperform | $21.00 -> $21.00 | High | View details for Wedbush rating of DoubleDown Interactive (NASDAQ:DDI) on 2/12/2025 |
IMAX IMAX | $22.47
+3.2% | 2/12/2025 | Reiterated by | Wedbush | Analyst Alicia Reese | Outperform -> Outperform | $32.00 -> $32.00 | Medium | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/12/2025 |
Z Zillow Group | $62.57
+0.2% | 2/12/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Outperform | $100.00 -> $100.00 | High | View details for Wedbush rating of Zillow Group (NASDAQ:Z) on 2/12/2025 |
SAGE Sage Therapeutics | $7.43
+0.8% | 2/12/2025 | Reiterated by | Wedbush | Analyst Laura Chico | Neutral -> Neutral | $6.00 -> $6.00 | Low | View details for Wedbush rating of Sage Therapeutics (NASDAQ:SAGE) on 2/12/2025 |
BCAX Bicara Therapeutics | $12.16
+3.4% | 2/12/2025 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $31.00 -> $31.00 | Low | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 2/12/2025 |
ARVN Arvinas | $8.60
+12.4% | 2/11/2025 | Reiterated by | Wedbush | - | Outperform | $57.00 | Medium | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 2/11/2025 |
CXW CoreCivic | $22.17
+1.0% | 2/11/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform | $30.00 | High | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 2/11/2025 |
VYGR Voyager Therapeutics | $3.16
+1.0% | 2/11/2025 | Reiterated by | Wedbush | Analyst Y. Zhong | Outperform | $11.00 -> $9.00 | High | View details for Wedbush rating of Voyager Therapeutics (NASDAQ:VYGR) on 2/11/2025 |
SHOP Shopify | $83.65
-0.4% | 2/11/2025 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform | $125.00 -> $125.00 | Medium | View details for Wedbush rating of Shopify (NYSE:SHOP) on 2/11/2025 |
TSEM Tower Semiconductor | $35.47
+4.3% | 2/11/2025 | Reiterated by | Wedbush | Analyst M. Bryson | Outperform | $60.00 | Low | View details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 2/11/2025 |
MCD McDonald's | $310.82
+0.6% | 2/11/2025 | Target Raised by | Wedbush | Analyst Nick Setyan | Outperform -> Outperform | $320.00 -> $330.00 | Low | View details for Wedbush rating of McDonald’s (NYSE:MCD) on 2/11/2025 |
WDC Western Digital | $36.51
+2.5% | 2/10/2025 | Reiterated by | Wedbush | Analyst Matt Bryson | Outperform -> Outperform | $95.00 -> $95.00 | Low | View details for Wedbush rating of Western Digital (NASDAQ:WDC) on 2/10/2025 |
SWTX SpringWorks Therapeutics | $37.89
+0.4% | 2/10/2025 | Reiterated by | Wedbush | Analyst David Nierengarten | Outperform -> Outperform | $77.00 -> $77.00 | Medium | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/10/2025 |
ROKU Roku | $58.46
+0.1% | 2/10/2025 | Reiterated by | Wedbush | - | Outperform | $100.00 -> $100.00 | Medium | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/10/2025 |
MNKD MannKind | $4.54
+0.2% | 2/10/2025 | Initiated by | Wedbush | Analyst Y. Zhong | Outperform | $11.00 | High | View details for Wedbush rating of MannKind (NASDAQ:MNKD) on 2/10/2025 |
EXPE Expedia Group | $151.15
-0.9% | 2/7/2025 | Reiterated by | Wedbush | - | Neutral | $180.00 -> $215.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 2/7/2025 |
AXTI AXT | $1.19
+1.7% | 2/7/2025 | Reiterated by | Wedbush | - | Outperform | $5.50 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/7/2025 |
RBLX Roblox | $59.76
+1.1% | 2/7/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform | $83.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 2/7/2025 |
SAFE Safehold | $15.28
+0.7% | 2/7/2025 | Reiterated by | Wedbush | Analyst Richard Anderson | Neutral -> Neutral | $20.00 -> $19.00 | Low | View details for Wedbush rating of Safehold (NYSE:SAFE) on 2/7/2025 |
NBIX Neurocrine Biosciences | $101.38
+1.3% | 2/7/2025 | Target Lowered by | Wedbush | Analyst Laura Chico | Outperform -> Outperform | $157.00 -> $147.00 | High | View details for Wedbush rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/7/2025 |
PINS Pinterest | $25.17
-1.1% | 2/7/2025 | Target Raised by | Wedbush | Analyst S. Devitt | Outperform -> Outperform | $38.00 -> $46.00 | Medium | View details for Wedbush rating of Pinterest (NYSE:PINS) on 2/7/2025 |
TTWO Take-Two Interactive Software | $212.77
+0.6% | 2/7/2025 | Reiterated by | Wedbush | Analyst M. Pachter | Outperform -> Outperform | $215.00 -> $215.00 | High | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 2/7/2025 |
SWI SolarWinds | $18.49
| 2/7/2025 | Downgraded by | Wedbush | Analyst D. Ives | Outperform -> Neutral | $20.00 -> $18.50 | High | View details for Wedbush rating of SolarWinds (NYSE:SWI) on 2/7/2025 |
AMZN Amazon.com | $172.51
-1.0% | 2/7/2025 | Reiterated by | Wedbush | Analyst Scott Devitt | Outperform -> Outperform | $280.00 -> $280.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 2/7/2025 |
DENN Denny's | $3.11
+5.1% | 2/7/2025 | Upgraded by | Wedbush | Analyst Nick Setyan | Neutral -> Outperform | $6.00 -> $10.00 | Medium | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/7/2025 |
BCAX Bicara Therapeutics | $12.16
+3.4% | 2/5/2025 | Upgraded by | Wedbush | Analyst D. Nierengarten | Strong-Buy | | High | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 2/5/2025 |
KURA Kura Oncology | $5.90
+2.6% | 2/6/2025 | Target Raised by | Wedbush | Analyst Robert Driscoll | Outperform -> Outperform | $34.00 -> $36.00 | High | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 2/6/2025 |
CVNA Carvana | $211.03
+0.8% | 2/6/2025 | Reiterated by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $250.00 -> $250.00 | Medium | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/6/2025 |
ORLY O'Reilly Automotive | $1,390.90
+1.9% | 2/6/2025 | Target Raised by | Wedbush | Analyst Seth Basham | Neutral -> Neutral | $1,200.00 -> $1,350.00 | Low | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/6/2025 |
BCAX Bicara Therapeutics | $12.16
+3.4% | 2/6/2025 | Initiated by | Wedbush | Analyst David Nierengarten | Outperform | $31.00 | High | View details for Wedbush rating of Bicara Therapeutics (NASDAQ:BCAX) on 2/6/2025 |
AMD Advanced Micro Devices | $87.50
-0.9% | 2/5/2025 | Reiterated by | Wedbush | - | Outperform | $150.00 | Medium | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 2/5/2025 |
BYON Beyond | $4.11
+11.4% | 2/5/2025 | Reiterated by | Wedbush | - | Outperform | $15.00 | High | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/5/2025 |
CRSR Corsair Gaming | $6.03
| 2/5/2025 | Reiterated by | Wedbush | - | Outperform | $10.00 -> $12.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 2/5/2025 |
CMG Chipotle Mexican Grill | $48.13
+0.1% | 2/5/2025 | Target Lowered by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $69.00 -> $64.00 | High | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 2/5/2025 |
MTH Meritage Homes | $65.13
+3.6% | 2/4/2025 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $103.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 2/4/2025 |
ABNB Airbnb | $112.70
+0.1% | 2/4/2025 | Reiterated by | Wedbush | - | Outperform | $155.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 2/4/2025 |
